Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01785017 · ClinicalTrials.gov registry record

The Effects of a Standardized Management Plan on Children With Critical Asthma

A clinical trial of Asthma and Children, sponsored by Boston Children's Hospital.

Completed
Registry status
273
Enrollment target
1
Study location

NCT01785017 is a study of Asthma and Children that has completed, run by Boston Children's Hospital. The registered enrollment target is 273 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01785017, a study of Asthma and Children, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
273 participants
Enrollment target
1
Study location

Study Summary

A Standardized Clinical Assessment Management Plan (SCAMP) has been developed and implemented at Boston Children Hospital to decrease variations in clinical practice in critical asthma therapies for children. The primary aim is to determine whether a Critical Asthma SCAMP can improve clinical outcome.

Conditions Studied

Study Locations (1)

Massachusetts

  • Boston Childrens Hospital - Boston

Trial Details

FieldValue
Enrollment Target 273 participants
Start Date 2013-01
Est. Completion 2016-12

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT01785017

The ClinicalTrials.gov registry entry for NCT01785017 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (83% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.

NCT01785017 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01785017 about?

NCT01785017 is a clinical study titled "The Effects of a Standardized Management Plan on Children With Critical Asthma". A Standardized Clinical Assessment Management Plan (SCAMP) has been developed and implemented at Boston Children Hospital to decrease variations in clinical practice in critical asthma therapies for children. The primary aim is to determine whether a Critical Asthma SCAMP can improve clinical outcom...

What is the current status of trial NCT01785017?

This trial is currently completed. The enrollment target is 273 participants. The study started on 2013-01. Estimated completion is 2016-12.

What conditions does trial NCT01785017 study?

This clinical trial studies the following conditions: Asthma, Children.

Who is sponsoring clinical trial NCT01785017?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01785017 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.